Entwine Bio, founded in San Francisco, California, is a pioneering software company focused on AI-driven proteome engineering through RNA splicing control. Their core mission is to revolutionize biological engineering by enabling the precise engineering of any protein in any cell. Entwine Bio's innovative approach leverages advanced AI algorithms to program RNA splicing, opening new avenues in biotechnology and therapeutic development.
Notable figures associated with Entwine Bio include co-founders Mona Khalaj, who serves as CEO and Acting CSO, and Colin McNally. The company also benefits from the expertise of academic cofounders and advisors such as Vijay Ramani from The Gladstone Institutes, Hani Goodarzi from UCSF and the Arc Institute, and Balyn Zaro from UCSF. Entwine Bio's groundbreaking work has positioned it as a significant player in the biotech industry, with the potential to make substantial impacts on medical research and treatment methodologies.
